EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrating the Idylla™ System Alongside a Real-Time Polymerase Chain Reaction and Next-Generation Sequencing for Investigating Gene Fusions in Pleural Effusions from Non-Small-Cell Lung Cancer Patients: A Pilot Study

Stefania Scarpino, Alvaro Leone iD, Dino Galafate, Francesco Pepe iD, Umberto Malapelle iD, Sandra Villani, Enrico Giarnieri iD, Giulio Maurizi, Claudia De Vitis iD, Rita Mancini, Massimiliano Mancini iD, Arianna Di Napoli iD und 2 weitere

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25147594 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Stefania Scarpino und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Molecular Medicine, Morphologic and Molecular Pathology Unit, St. Andrea University Hospital, Sapienza University of Rome,…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, High-Throughput Nucleotide Sequencing, Real-Time Polymerase Chain Reaction. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Association for Cancer Research (AIRC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Malignant pleural effusion (MPE) from patients with advanced non-small-cell lung cancer (NSCLC) has been proven valuable for molecular analysis; however, simultaneous detection of driver fusions in MPE is still challenging. In this study, we investigated the Idylla™ GeneFusion Panel, a stand-alone test in tissue samples, in the evaluation of ALK, ROS1, RET and MET ex14 skipping mutations in MPE and compared its performance with routine reference methods (Real-time-based and Next-generation Sequencing—NGS). The inclusion criteria for sample selection were as follows: advanced NSCLC harboring ALK, ROS1, RET fusions or MET exon-skipping alterations and the availability of MPE collected at diagnosis or disease progression. Molecular alterations have been investigated on tissue by fluorescence in situ hybridization (FISH) or Real-time PCR or NGS. For molecular profiling with the Idylla™ GeneFusion, 200 µL of MPE supernatants combined with 50 µL of RNA Later solution were loaded into the Idylla™ cartridge without cfRNA extraction. The Idylla™ GeneFusion Assay performed on MPEs was able to confirm molecular profile, previously diagnosed with conventional methods, in all cases. Our data confirm that MPE are suitable material for investigating fusion alterations. The Idylla™ GeneFusion, although indicated for investigation of tissue samples, offers the possibility of performing a molecular characterization of supernatants without undertaking the entire cfRNA extraction procedure providing a rapid and reliable strategy for the detection of actionable genetic alterations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsHigh-Throughput Nucleotide SequencingReal-Time Polymerase Chain ReactionHumansPilot ProjectsMaleFemaleAgedMiddle AgedPleural Effusion, MalignantOncogene Proteins, FusionGene FusionAdultMutationAnaplastic Lymphoma KinaseAged, 80 and overProto-Oncogene Proteins c-retProtein-Tyrosine KinasesProto-Oncogene Proteins

Stichwörter der Autor:innen

Idylla™ systemNSCLCcfRNAgene fusionmalignant pleural effusion

Substanzen

Oncogene Proteins, FusionROS1 protein, humanAnaplastic Lymphoma KinaseProto-Oncogene Proteins c-retProtein-Tyrosine KinasesProto-Oncogene Proteins

Autor:innen und Institutionen

  • Department of Clinical and Molecular Medicine, Morphologic and Molecular Pathology Unit, St. Andrea University Hospital, Sapienza University of Rome, 00189 Rome, Italy.
  • Anatomic Pathology Unit, San Camillo-Forlanini Hospitals, 00152 Rome, Italy.
  • Department of Public Health, University of Naples Federico II, 80138 Naples, Italy.
  • Department of Thoracic Surgery, Sant' Andrea Hospital, Sapienza University of Rome, 00189 Rome, Italy.

ORCID-Profile: Alvaro Leone, Francesco Pepe, Umberto Malapelle, Enrico Giarnieri, Claudia De Vitis, Massimiliano Mancini, Arianna Di Napoli, Andrea Vecchione, Emanuela Pilozzi

Förderung

  • Italian Association for Cancer Research (AIRC)

Zitieren

APA

Scarpino, S., Leone, A., Galafate, D., Pepe, F., Malapelle, U., Villani, S., Giarnieri, E., Maurizi, G., De Vitis, C., Mancini, R., Mancini, M., Di Napoli, A., Vecchione, A., & Pilozzi, E. (2024). Integrating the Idylla™ System Alongside a Real-Time Polymerase Chain Reaction and Next-Generation Sequencing for Investigating Gene Fusions in Pleural Effusions from Non-Small-Cell Lung Cancer Patients: A Pilot Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25147594

Vancouver

Scarpino S, Leone A, Galafate D, Pepe F, Malapelle U, Villani S, et al. Integrating the Idylla™ System Alongside a Real-Time Polymerase Chain Reaction and Next-Generation Sequencing for Investigating Gene Fusions in Pleural Effusions from Non-Small-Cell Lung Cancer Patients: A Pilot Study. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25147594

BibTeX
@article{Scarpino2024,
  author = {Scarpino, Stefania and Leone, Alvaro and Galafate, Dino and Pepe, Francesco and Malapelle, Umberto and Villani, Sandra and Giarnieri, Enrico and Maurizi, Giulio and De Vitis, Claudia and Mancini, Rita and Mancini, Massimiliano and Di Napoli, Arianna and Vecchione, Andrea and Pilozzi, Emanuela},
  title = {Integrating the Idylla™ System Alongside a Real-Time Polymerase Chain Reaction and Next-Generation Sequencing for Investigating Gene Fusions in Pleural Effusions from Non-Small-Cell Lung Cancer Patients: A Pilot Study},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25147594}
}
Kostenlos starten →